An animal model to evaluate the protective efficacy of Haemophilus influenzae type b conjugate vaccines

Biotechnology and Bioprocess Engineering

Volumn 9, Issue 6, 2004, Pages 490-494

  Kim, Hyun Sung ^a,b   Yoo, Tae Hyeon ^a   Jang, Yang Suk ^a,c   Kim, Hun ^a   Park, Jin Yong ^a,c   Hur, Byung Ki ^b   Ryu, Yeon Woo ^c   Kim, Jong Su ^a  

^a Green Cross Company   (South Korea)

^b Inha University   (South Korea)

^c Ajou University   (South Korea)

Author keywords

Challenge; Combination of mucin and hemoglobin; Conjugate vaccine; Efficacy; Haemophilus influenzae type b; Virulence enhancement agent

Indexed keywords

EID: 33745628861     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02933491     Document Type: Article

References (28)

1. Cochi, S. L., C. V. Broome, and A. W. Hightower (1985) Immunization of US children with Haemophilus influenzae type b polysaccharide vaccine. J. Am. Med. Ass. 253: 521-529.
2. Coulehan, J. L., R. H. Michaels, K. E. Williams, D. K. Lemley, C. Q. Jr. North, T. K. Welty, and K. D. Rogers (1976) Bacterial meningitis in Navajo indians. Public Health Rep. 91:464-468.
3. Tarr, P. I. and G. Peter (1978) Demographic factors in the epidemiology of Haemophilus influenzae meningitis in young children. J. Pediat. 92: 884-888.
4. Ward. J. (1991) Prevention of invasive Haemophilus influenzae type b disease: Lessons from vaccine efficacy trials. Vaccine 9: S17-24.
5. Pittman M. (1933) The action of type-specific H. influenzae antiserum. J. Exp. Med. 58: 683-706.
6. Onodera, M. (2002) Silicone rubber membrane bioreactors for bacterial cellulose production. Biotechnol. Bioprocess Eng. 10:289-294.
7. Immunization practices advisory (ACIP) (1986) Update: Prevention of Haemophilus influenzae type b disease. Morbid. Mortal. Week. Rep. 35: 170.
8. Heath, P. T. and M. Fracp (1998) Haemophilus influenzae type b conjugate vaccines: A review of efficacy data. Pediatr. Infect. Dis. J. 17: S117-122.
9. Burans, J. P., F. H. Kruszeski, M. Lynn, and M. Solotrovsky (1981) Kinetics of Haemophilus influenzae type b infection in normal and ribosom-immunized mice using intraperitoneal and intracerebral routes of inoculation. Br. J. Exp. Pathol. 62: 496-503.
10. Kaplan, S. L., E. O. Mason, Jr., and B. L. Wiedermann (1983) Role of adherence in the pathogenesis of Haemophilus influenzae type b infection in infant rats. Infec. Immun. 42: 612-617.
11. Smith, A. L., D. H. Smith, D. R. Averill, Jr., J. Marino, and E. R. Moxon (1983) Haemophilus influenzae type b bacteremia and meningitis infant rabbits after intranasal inoculation. J. Lab. Clin. Med. 102: 939-946.
12. Moxon, E. R., A. L. Smith, D. R. Averill, and D. H. Smith (1974) Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J. Infect. Dis. 129: 154-162.
13. Marks, M. I., E. J. Ziegler, H. Douglas, and L. B. Corbeil (1982) Lethal Haemophilus influenzae type b infection in mice. Infection 10: 261-266.
14. Broueur, B. R., Y. Larose, P. Tsang, J. Hamel, F. Ashton, and A. Ryan (1985) Protection against infection with Neisseria meningitides group B serotype 2b by passive immunization with serotype specific monoclonal antibody. Infect. Immun. 50: 510-516.
15. Rodriguez, S. S., J. F. I. Bourzac, O. M. Chang, M. F. Medina, E. M. Carnago, and Y. L. Hernandez (1999) Virulence enhancement agents for Haemophilus influenzae type b infection in mice. Lab. Anim. Sci. 49: 95-98.
16. Halesy, N. A., T. L. Johansen, L. C. Bowman, and M. P. Glode (1983) Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model. Infec. Immun. 39: 1196-1200.
17. Brodeur, B. R., P. S. Tsang, J. Hamel, Y. Larose, and S. Montplaisir (1986) Mouse models of infection for Neisseria meningitides B, 2b and Haemophilus influenzae type b diseases. Can. J. Microbiol. 32: 33-37.
18. Kristensen, K., and M. W. Bentzon (1992) Relation between enzyme-linked immunoserbent assay and radioimmunoassay for detection of antibodies to the capsular polysaccharide of Haemophilus influenzae type b. APMIS 100: 142-146.
19. Farr, R. S. (1958) A quantitative immunochemical measurement of the primary interaction between I*BSA and antibody. J. Infect. Dis. 103: 239-262.
20. Kuo, J. S. C., N. Monji, R. S. Schwalbe, and D. W. McCoy (1981) A radioactive antigen-binding assay for the measurement of antibody to Haemophilus influenzae type b capsular polysaccharide. J. Immunol. Methods 43: 35-47.
21. Warlaw, A. C. (1985) Practical Statistics for Experimental Biologists. JohnWiley Wiley & Sons Ltd, USA.
22. Corbeil, G. A., C. P. Kenny, and G. Laverne (1976) Iron as a replacement for mucin in the establishment of meningococcal infection in mice. Can. J. Microbiol. 22: 832-838.
23. Miller, C. P. (1933) Experimental meningococcal infection of mice. Science 78: 340-341.
24. Ward, J., G. Brenneman, G. W. Leston, and W. L. Heyward (1990) Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska native infants. N. Engl. J. Med. 323: 1391-1401.
25. Hong, H. J. and S. T. Kim (2002) Antibody engineering. Biotechnol. Bioprocess Eng. 7: 150-154.
26. Frasch, C. E. (1994) Regulatory perspectives in vaccine licensure, pp.435-453. In: Ellis R. W. D. W. Granoff (eds.). Development and Clinical Uses of Haemophilus b Conjugate Vaccine. Mercel Dekkar, New York, USA.
27. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children. (1995) Morb. Mortal. Wkly. Rep. 42: 296-298.
28. Granoff, D. M. (2001) Assessing efficacy of Haemophilus influenzae type b combination vaccines. Clin. Infect. Dis. 55: S278-287.